Silo Pharma, Inc. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Silo Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q4 2024.
  • Silo Pharma, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.81M, a 55.8% decline year-over-year.
  • Silo Pharma, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$4.71M, a 22% decline year-over-year.
  • Silo Pharma, Inc. annual Operating Income (Loss) for 2024 was -$4.71M, a 22% decline from 2023.
  • Silo Pharma, Inc. annual Operating Income (Loss) for 2023 was -$3.86M, a 6.28% decline from 2022.
  • Silo Pharma, Inc. annual Operating Income (Loss) for 2022 was -$3.63M, a 32.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$4.71M -$1.81M -$650K -55.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$4.06M -$1.01M -$237K -30.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$3.82M -$1M +$112K +10.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$3.93M -$880K -$76K -9.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$3.86M -$1.16M +$493K +29.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$4.35M -$773K +$176K +18.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$4.52M -$1.11M -$621K -126% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$3.9M -$803K -$276K -52.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$3.63M -$1.66M -$715K -75.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$2.91M -$949K -$485K -105% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$2.43M -$494K -$57.4K -13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$2.37M -$527K +$374K +41.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$2.74M -$942K -$456K -93.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$2.29M -$464K +$95K +17% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.38M -$437K +$560K +56.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 -$2.94M -$901K -$742K -465% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$2.2M -$487K -$163K -50.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$2.04M -$559K -$316K -130% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$1.72M -$997K -$807K -425% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$915K -$159K +$15.2K +8.71% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$930K -$323K -$21.4K -7.07% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-05-17
Q3 2019 -$909K -$243K -$161K -199% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$748K -$190K -$114K -149% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$634K -$175K -$39.7K -29.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$594K -$302K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$81.2K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$76.1K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$135K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.